Cambodia reported strong gains in routine immunisation over two decades, and the authors noted the country conducted one of Southeast Asia’s most successful COVID-19 vaccine campaigns. Yet the study team warned that the epidemiological environment is shifting. Climate change and environmental degradation are changing vector habitats and pathogen ranges; urbanisation and increased regional mobility are concentrating susceptible populations and accelerating pathogen spread. Intensified human-animal interactions raise zoonotic risk, the authors observed, placing Cambodia on the frontline of potential epidemic and pandemic threats.
The national vaccine policy in Cambodia has historically prioritised childhood immunisation. The authors argued that this focus, while effective for established priorities, is insufficient for preparedness against emergent threats. They proposed a deliberate transition from a delivery-centric immunisation agenda toward a broader vaccine preparedness agenda that integrates surveillance signals, flexible prioritisation, and cross-sectoral collaboration. The study team recommended reframing policy goals so that routine programmes and preparedness functions operate as complementary, not competing, activities.
Data-driven prioritisation formed a central recommendation. The authors called for strengthened pathogen surveillance and routine genomic monitoring to detect novel threats early and to inform vaccine decisions. They highlighted laboratory capacity as a necessary foundation for such systems. The source did not provide granular operational plans, diagnostic platforms to be deployed, or timelines; rather, the study outlined capacity domains that require investment—epidemiologic surveillance networks, specimen transport systems, and genomic sequencing capability—without specifying resource estimates or phased implementation steps.
Rapid vaccine development and deployment demand regulatory agility, the authors noted. They proposed regulatory readiness as a pillar of preparedness, arguing the regulatory environment should support emergency review pathways and facilitate access to rapid vaccine platforms when indicated. The paper did not list specific regulatory reforms or legislative changes; it framed regulatory preparedness conceptually, calling for alignment with international standards and the capacity to evaluate novel platforms under emergency conditions.
The authors recommended reinforcing resilient vaccine delivery systems so that any new product—whether for seasonal outbreaks or novel pathogens—can reach prioritized populations. They also called for sustainable financing mechanisms to maintain both routine programmes and surge capacity. Regional partnerships were identified as critical for information sharing, pooled procurement, and coordinated response. The source discussed these elements at a strategic level; it did not provide concrete financing models, partner agreements, or costed scenarios.
The study team named several pathogens and scenarios to guide preparedness planning. These included H5N1, dengue, Japanese encephalitis, rabies, and hypothetical Disease X events. The authors used these examples to illustrate varying vaccine needs: zoonotic avian threats, vector-borne endemic pathogens, and unknown emergent agents requiring platform-based responses. The source emphasised prioritisation based on surveillance signals and risk assessment rather than prescribing a fixed product list.
The authors concluded by proposing a national framework centred on surveillance-informed prioritisation, laboratory and genomic strengthening, regulatory readiness, resilient delivery, sustainable financing, and strengthened regional links. They also identified several unanswered implementation questions. How will One Health collaboration be operationalised across human, animal, and environmental sectors? What funding streams will sustain genomic and laboratory capacity outside of crises? Which regulatory mechanisms will be adapted to evaluate emergency-use vaccine platforms? The paper did not supply timelines, pilot projects, or cost estimates to resolve these gaps. These represent the immediate programmatic and policy challenges Cambodia and partners will need to address to move from conceptual preparedness to implementable action.